Bioss Antibodies

Leading #antibody developer and manufacturer, with over 14,000 primary antibodies and more than 300,000 derived products to accelerate research and discovery.

[Bioss Antibodies @Biossusa]

Presenting antibody-related research at a 2026 conference? Bioss is launching our 2026 Travel Grants to help get your research there!
Submit your abstract here for a chance to win:
https://t.co/xaTeM7AIdB

Which conference is at the top of your list for 2026?

[Bioss Antibodies @Biossusa]

Working on Nipah virus studies? See our latest blog and explore Nipah virus-related recombinant proteins now available from Bioss.

View here: https://t.co/WcMCIY0WTZ

[Bioss Antibodies @Biossusa]

If you’re choosing between antibodies, citation history is often the fastest way to estimate:

🔬 success probability
📉 experimental risk
🧪 reviewer confidence

Read the full breakdown in our new blog 👇
https://t.co/xpZJKzTM6J

[Bioss Antibodies @Biossusa]

Join the Bioss team at Booth 2318 to explore our latest solutions for neuroscience research at NEUROSCIENCE 2025!

[Bioss Antibodies @Biossusa]

In the landscape of biomedical research, few methodologies have reshaped our comprehension of disease pathogenesis as fundamentally as immunohistochemistry; this technique has become a cornerstone of diagnostic and investigative pathology.

Read here: https://t.co/wC0NdbT2xv

[Bioss Antibodies @Biossusa]

👉 Download your free booklet now and bring clarity and confidence to every IHC experiment: https://t.co/YVkp1LV3Of

[Bioss Antibodies @Biossusa]

This month’s IHC spotlight features bsm-60737R (CD11b), bsm-54767R (CD44), bsm-54132R (AIF1), and bsm-52455R (Ki-67)— critical markers for tracking immune activation, inflammation, microglial response, and cell proliferation.

Visit https://t.co/dcNCbnsZ5q to learn more.

[Bioss Antibodies @Biossusa]

Whether you’re optimizing assays or refining your staining protocols, HRP polymer detection offers the precision and sensitivity needed to elevate your IHC results.

Explore how it works and why it’s redefining immunohistochemistry: https://t.co/UbsK1gpTfv.

[Bioss Antibodies @Biossusa]

We're here to help you stretch your grant funding further with our Best Price offer! Take the most of your research budget now and submit a comparable lower-priced item to us for a discount to apply on your order!

🔗 https://t.co/RuB1HO2v7r

[Bioss Antibodies @Biossusa]

AI is transforming in vitro diagnostics (IVD) by accelerating the discovery and optimization of antibody pairs for ELISA, lateral flow assays, and multiplex platforms.

Read here: https://t.co/7Aj6K1iiHw

[Bioss Antibodies @Biossusa]

A new study in Alzheimer’s & Dementia shows that drugs already used for Parkinson’s disease may improve memory and cognition in Alzheimer’s patients. Could targeting dopamine be the next breakthrough for Alzheimer’s?

Learn more here: https://t.co/YkUdsm9tTm

[Bioss Antibodies @Biossusa]

Recombinant Proteins, Refined for Your Research 🧬

With 9,000+ recombinant proteins available, Bioss supports early discovery to large-scale workflows— without compromising performance.

Explore the collection: https://t.co/Lx39J9DteB

[Bioss Antibodies @Biossusa]

Bioss Knockdown-Validated Recombinant Antibodies are paired with matched lysates for enhanced reliability and better signal specificity.

Explore our portfolio designed to boost confidence in your results here: https://t.co/X94glihpdb

[Bioss Antibodies @Biossusa]

For a limited-time only: Receive 20% off Bioss Conjugated Antibodies!

Search your targets of interest here: https://t.co/uSwzZNRsNE.

[Bioss Antibodies @Biossusa]

Whether you're outfitting a core lab or running a single project, every dollar counts. We're here to help you stretch your grant funding further— but this limited-time offer won't be around much longer... make the most of your research budget now!

🔗 https://t.co/dzIcmlnXxe

[Bioss Antibodies @Biossusa]

Antibodies power modern research—but not all antibodies are created equal. Batch-to-batch variability can make or break results, which is why researchers are increasingly asking: Should I use recombinant monoclonal antibodies or polyclonals?

🔗 Read here: https://t.co/xwGJ1mE3YI

[Bioss Antibodies @Biossusa]

Bioss Knockdown-Validated Recombinant Antibodies are paired with matched lysates for enhanced reliability and better signal specificity.

Explore our portfolio designed to boost confidence in your results here: https://t.co/HCanJtx0ke

[Bioss Antibodies @Biossusa]

For a limited-time only: Receive 20% off Bioss Conjugated Antibodies!

Search your targets of interest here: https://t.co/Q84ajlOQBu.

[Bioss Antibodies @Biossusa]

Now available...AbBy Fluor™ NHS Esters for consistent, high-quality labeling!

View here: https://t.co/5dZxluZGh3

[Bioss Antibodies @Biossusa]

Discover Bioss' collection of antibodies for mitochondrial markers: https://t.co/bioEQCtrmT